# Polaryx Therapeutics, Inc.: Form 8-K, filed May 28, 2026

- Company: [Polaryx Therapeutics, Inc.](/companies/plyx.md) (CIK 2075320)
- Form: 8-K
- Filed: 2026-05-28
- Accepted by EDGAR: May 28, 2026, 16:31 ET
- Period: 2026-05-27
- Accession: 0001213900-26-062155
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2075320/000121390026062155/ea0291692-8k_polaryx.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2075320/000121390026062155/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2075320/000121390026062155/ea0291692-8k_polaryx.htm

Filed May 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-062155. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.